46-60 of 831
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
NeuroFrontiersSPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
BCMA mRNA CAR-T Shows Durable Benefit in MG
NeuroFrontiersBCMA mRNA CAR-T Shows Durable Benefit in MG
RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
NeuroFrontiersRAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
NeuroFrontiersNext-Generation MS Care: The Promise of Cell-Based Therapeutics
Omaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
NeuroFrontiersOmaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
FA hiPSCs in Translational Drug Development
NeuroFrontiersFA hiPSCs in Translational Drug Development
- advertisement
Proactive Pregnancy Planning and Reproductive Care in MS
NeuroFrontiersProactive Pregnancy Planning and Reproductive Care in MS
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
NeuroFrontiersApplying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
Challenging the Status Quo in Schizophrenia Treatment
On the Frontlines of SchizophreniaChallenging the Status Quo in Schizophrenia Treatment
The Social Brain in Schizophrenia
On the Frontlines of SchizophreniaThe Social Brain in Schizophrenia
Addressing Social and Systemic Barriers in Schizophrenia
On the Frontlines of SchizophreniaAddressing Social and Systemic Barriers in Schizophrenia
Nutrition and the Gut-Brain Connection in Schizophrenia
On the Frontlines of SchizophreniaNutrition and the Gut-Brain Connection in Schizophrenia
- advertisement
Emerging Serum microRNAs as Early Signals in MS
NeuroFrontiersEmerging Serum microRNAs as Early Signals in MS













































